Literature DB >> 14769750

Brain natriuretic peptide in the management of heart failure: the versatile neurohormone.

Simon de Denus1, Chantal Pharand, David R Williamson.   

Abstract

Brain natriuretic peptide (BNP), also called B-type natriuretic peptide, is a member of a family of structurally related hormones, the natriuretic peptides. Current data suggest that measurement of BNP plasma concentrations is a useful tool in the diagnosis of acute heart failure in patients presenting to an emergency department with acute dyspnea. Furthermore, BNP constitutes a promising new marker of prognosis after an acute coronary syndrome episode and in patients with chronic heart failure. Nesiritide, the human recombinant form of BNP, is a new vasodilator used in the treatment of acute heart failure that has several potential advantages over current drug therapy.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14769750     DOI： 10.1378/chest.125.2.652

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


  8 in total

Review 1.  The multifaceted role of natriuretic peptides in metabolic syndrome.

Authors:  Prasanna K Santhekadur; Divya P Kumar; Mulugeta Seneshaw; Faridoddin Mirshahi; Arun J Sanyal
Journal:  Biomed Pharmacother       Date:  2017-06-07       Impact factor: 6.529

2.  Usefulness of B-type natriuretic peptide in elderly patients with acute dyspnea.

Authors:  Patrick Ray; Martine Arthaud; Yannick Lefort; Sophie Birolleau; Catherine Beigelman; Bruno Riou
Journal:  Intensive Care Med       Date:  2004-10-22       Impact factor: 17.440

Review 3.  [Are neurohumoral parameters predictive for the efficacy of cardiac resynchronization therapy? The role of natriuretic peptides].

Authors:  A-M Sinha; O-A Breithardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2006

4.  Can NT-proBNP be used as a criterion for heart failure hospitalization in emergency room?

Authors:  Tuba Cimilli Ozturk; Erol Unluer; Arzu Denizbasi; Ozlem Guneysel; Ozge Onur
Journal:  J Res Med Sci       Date:  2011-12       Impact factor: 1.852

5.  The effects of wenxin keli on left ventricular ejection fraction and brain natriuretic Peptide in patients with heart failure: a meta-analysis of randomized controlled trials.

Authors:  Yu Chen; Xingjiang Xiong; Chunmei Wang; Chenggang Wang; Ying Zhang; Xingyong Zhang; Yonghong Gao; Yanhui Xing; Jun Li; Jie Wang; Xiaoqiu Liu; Yanwei Xing
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-27       Impact factor: 2.629

6.  Concurrence of Inappropriate Antidiuretic Hormone Secretion and Cerebral Salt Wasting Syndromes after Traumatic Brain Injury.

Authors:  Bo Shen; Lin Li; Ting Li
Journal:  Front Neurosci       Date:  2017-09-06       Impact factor: 4.677

Review 7.  Acute heart failure syndromes: clinical scenarios and pathophysiologic targets for therapy.

Authors:  Leonardo De Luca; Gregg C Fonarow; Kirkwood F Adams; Alexandre Mebazaa; Luigi Tavazzi; Karl Swedberg; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2007-06       Impact factor: 4.654

Review 8.  Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions.

Authors:  Michael A Burke; William G Cotts
Journal:  Heart Fail Rev       Date:  2007-03-08       Impact factor: 4.654
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.